ES557387A0 - Un procedimiento para la preparacion de polipeptidos inmunogenicos - Google Patents

Un procedimiento para la preparacion de polipeptidos inmunogenicos

Info

Publication number
ES557387A0
ES557387A0 ES557387A ES557387A ES557387A0 ES 557387 A0 ES557387 A0 ES 557387A0 ES 557387 A ES557387 A ES 557387A ES 557387 A ES557387 A ES 557387A ES 557387 A0 ES557387 A0 ES 557387A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
immunogenic polypeptides
immunogenic
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557387A
Other languages
English (en)
Other versions
ES8802457A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES557387A0 publication Critical patent/ES557387A0/es
Publication of ES8802457A1 publication Critical patent/ES8802457A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
ES557387A 1985-05-30 1987-02-13 Un procedimiento para la preparacion de polipeptidos inmunogenicos Expired ES8802457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73941685A 1985-05-30 1985-05-30

Publications (2)

Publication Number Publication Date
ES557387A0 true ES557387A0 (es) 1988-07-01
ES8802457A1 ES8802457A1 (es) 1988-07-01

Family

ID=24972206

Family Applications (4)

Application Number Title Priority Date Filing Date
ES555435A Expired ES8800274A1 (es) 1985-05-30 1986-05-29 Un procedimiento para la preparacion de un polipeptido-c-terminal p21ras
ES557386A Expired ES8801729A1 (es) 1985-05-30 1987-02-13 Un ensayo inmunometrio para proteina p21ras humana
ES557387A Expired ES8802457A1 (es) 1985-05-30 1987-02-13 Un procedimiento para la preparacion de polipeptidos inmunogenicos
ES557385A Expired ES8900246A1 (es) 1985-05-30 1987-02-13 Un procedimiento para la preparacion de anticuerpos especificos para uno de los miembros de la familia p 2 de proteinas

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES555435A Expired ES8800274A1 (es) 1985-05-30 1986-05-29 Un procedimiento para la preparacion de un polipeptido-c-terminal p21ras
ES557386A Expired ES8801729A1 (es) 1985-05-30 1987-02-13 Un ensayo inmunometrio para proteina p21ras humana

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557385A Expired ES8900246A1 (es) 1985-05-30 1987-02-13 Un procedimiento para la preparacion de anticuerpos especificos para uno de los miembros de la familia p 2 de proteinas

Country Status (6)

Country Link
EP (1) EP0203587A3 (es)
JP (1) JPS61289099A (es)
AU (1) AU600439B2 (es)
DK (1) DK253386A (es)
ES (4) ES8800274A1 (es)
NO (1) NO862144L (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733738A (en) * 1983-08-17 1998-03-31 Ligand Pharmaceuticals Polypeptide-induced monoclonal receptors to protein ligands
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
AU615876B2 (en) * 1985-08-21 1991-10-17 Oncogene Science, Inc. Immunoassay for the detection of Oncogene encoded products
DK354487A (da) * 1986-07-11 1988-01-12 Noboru Yanaihara Oncogen-relaterede peptider
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
US5112737A (en) * 1988-02-22 1992-05-12 Applied Biotechnology, Inc. Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
WO1989010375A1 (en) * 1988-04-22 1989-11-02 E.I. Du Pont De Nemours And Company Monoclonal antibodies specific for the harvey, kirsten and n ras proteins and their use as diagnostic reagents
DE68928470T2 (de) * 1988-08-12 1998-04-16 Ligand Pharm Inc Polypeptid-induzierte monoklonale Rezeptoren gegen Proteinliganden
CA2044333A1 (en) * 1990-06-12 1991-12-13 Jackson B. Gibbs Chemotherapeutic agents
US5965539A (en) * 1993-05-18 1999-10-12 Univeristy Of Pittsburgh Inhibitors of prenyl transferases
US5705686A (en) * 1993-05-18 1998-01-06 University Of Pittsburgh Inhibition of farnesyl transferase
US5834434A (en) * 1993-05-18 1998-11-10 University Of Pittsburgh Inhibitors of farnesyltransferase
US5602098A (en) * 1993-05-18 1997-02-11 University Of Pittsburgh Inhibition of farnesyltransferase
US6011175A (en) * 1993-05-18 2000-01-04 University Of Pittsburgh Inhibition of farnesyltransferase
US5840683A (en) * 1995-09-21 1998-11-24 Innapharma, Inc. Peptides inhibiting the oncogenic action of p21 ras
US5910478A (en) * 1995-09-21 1999-06-08 Innapharma, Inc. Peptidomimetics inhibiting the oncogenic action of p21 ras
US6221865B1 (en) 1995-11-06 2001-04-24 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
US6310095B1 (en) 1995-11-06 2001-10-30 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
US6204293B1 (en) 1995-11-06 2001-03-20 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
US6693123B2 (en) 1995-11-06 2004-02-17 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
US20020156257A1 (en) * 2001-03-29 2002-10-24 Chunhua Yan Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
AU2650984A (en) * 1983-02-14 1984-08-30 Arup Sen Synthetic polypeptides from viral oncogenes
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products

Also Published As

Publication number Publication date
ES557386A0 (es) 1988-02-16
AU600439B2 (en) 1990-08-16
ES8801729A1 (es) 1988-02-16
AU5805886A (en) 1986-12-04
ES557385A0 (es) 1989-05-16
DK253386D0 (da) 1986-05-29
ES555435A0 (es) 1987-10-16
JPS61289099A (ja) 1986-12-19
EP0203587A3 (en) 1989-08-09
ES8900246A1 (es) 1989-05-16
ES8802457A1 (es) 1988-07-01
NO862144L (no) 1986-12-01
ES8800274A1 (es) 1987-10-16
DK253386A (da) 1986-12-01
EP0203587A2 (en) 1986-12-03

Similar Documents

Publication Publication Date Title
ES557743A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES557387A0 (es) Un procedimiento para la preparacion de polipeptidos inmunogenicos
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES555668A0 (es) Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES555868A0 (es) Un procedimiento para la preparacion de sulfonamidas
ES557413A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES557772A0 (es) Un procedimiento para la preparacion de epipodofilotoxina
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES545298A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ES557427A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas
ES557019A0 (es) Un procedimiento para la preparacion de derivados aminicos
ES553703A0 (es) Un procedimiento para la preparacion de vesiculas de fosfoliptidos.
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES557435A0 (es) Un procedimiento para la preparacion de un hidrohaluro de oxazolindiona
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES556807A0 (es) Un procedimiento para la preparacion de nuevos 11-metileno-esteroides.
ES552988A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
ES552186A0 (es) Un procedimiento para la preparacion de 7-(dimetilaminometilen)amino-9a-metoximitosano cristalino